AIC
PBE icon

Archer Investment Corporation’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Archer Investment Corporation’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40
Closed -$2.33K – 678
2020
Q2 		$2.33K Buy
+40
New +$2.18K ﹤0.01% 555

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
PA
PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Archer Investment Corporation's PBE Position: Q3 2020 in Review

Archer Investment Corporation sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2020, closing a stake of 40 shares — an estimated $2.33K sold.

Archer Investment Corporation first reported a position in PBE in Q2 2020 and held it in 1 quarter. The position peaked at $2.33K in Q2 2020. 73 funds tracked by Wall St. Rank hold PBE as of Q3 2020.

  • Archer Investment Corporation reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2020 after selling out during the quarter.
  • Archer Investment Corporation sold 40 Invesco Biotechnology & Genome ETF shares in Q3 2020, an estimated $2.33K.
  • Archer Investment Corporation first reported a position in Invesco Biotechnology & Genome ETF in Q2 2020 and held it in 1 quarter.
  • Archer Investment Corporation's Invesco Biotechnology & Genome ETF position peaked at $2.33K in Q2 2020.
  • 73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2020.

Based on Archer Investment Corporation's 13F filing for Q3 2020, filed 13 Nov 2020.